Projects (133)

A phase III study testing LPRI-424 (dienogest and ethinyl estradiol) versus placebo for PCOS Sep 20, 2022 - Dec 31, 2024

A Randomised, Double-blind, Placebo-controlled Phase 2 Study with Open-label Extension to Assess the Efficacy and Safety of Namilumab in Subjects with Chronic Pulmonary Sarcoidosis Jan 1, 2023 - Aug 31, 2025

Wolfson Equipment bid 2023 - Confocal Imaging ZEISS Elyra 7 with Lattice SIM² Oct 1, 2024 - Sep 30, 2029

THrough knee AMputation impact on Quality of Life compared to abovE knee amputaTion (HAMLET) Jun 1, 2024 - Aug 31, 2030
HAMLET Trial – Through knee or not through knee

Phase 2 Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients with IPF May 1, 2022 - Jun 30, 2024

PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF INTRAVENOUS EFZOFITIMOD IN PATIENTS WITH PULMONARY SARCOIDOSIS Jan 1, 2023 - Jun 30, 2025

RDS Amputation PPI Apr 1, 2023 - Mar 31, 2024

The DRESSINg trial: A multicentre randomised controlled trial to assess the effectiveness of Dialkylcarbamoylchloride (DACC) coated post-operative dressings versus standard care in the prevention of Surgical Site Infection in clean or clean contaminated vascular surgery Oct 1, 2023 - Sep 30, 2026
Aims
This study aims to investigate the role of a new dressing (DACC) in preventing wound infection follow vascular surgery. This dressing has a special coating that binds to bacteria irreversibly, allowing them to be removed. The DACC dressings wil... Read More about The DRESSINg trial: A multicentre randomised controlled trial to assess the effectiveness of Dialkylcarbamoylchloride (DACC) coated post-operative dressings versus standard care in the prevention of Surgical Site Infection in clean or clean contaminated vascular surgery.

HIKE: A Data Package to Support Clinical Translation of Novel Microwave Probes for Peripheral Arterial Disease (MICRO-PAD) Nov 1, 2023 - Mar 3, 2025
This project will combine HYMS/Hull’s biomedical and clinical expertise in vascular biology with Emblation’s track record in bringing medical devices to market to validate and commercialise novel patented microwave probes for treatment of peripheral... Read More about HIKE: A Data Package to Support Clinical Translation of Novel Microwave Probes for Peripheral Arterial Disease (MICRO-PAD).

HEIF: Simplifying patient information for clinical trials Aug 1, 2023 - Jul 31, 2024
Clinical trials are the main mechanism for improving patient care. They are an important source of income for the University and HUTH. The output in terms of publications and impact generated contributes greatly to the REF submission.

In order to... Read More about HEIF: Simplifying patient information for clinical trials.

FREEDM: Continous glucose monitoring use in adults with type 2 diabetes on basal insulin May 1, 2023 - Mar 31, 2027
Real-time glucose monitoring using FreeStyle Libre 3 in adults with type 2 diabetes on basal insulin plus SGLT2 inhibitors and/or GLP-1.

Understanding barriers and facilitators to implementing physical activity interventions for patients receiving immune checkpoint inhibitor therapy: A qualitative study Nov 1, 2023 - Jul 31, 2026
Immune checkpoint inhibitors (ICIs) have huge potential for the treatment of metastatic melanoma, renal, head and neck, and lung cancers. While recent research shows that exercise improves chemoradiotherapy outcomes, its role as an adjunctive treatme... Read More about Understanding barriers and facilitators to implementing physical activity interventions for patients receiving immune checkpoint inhibitor therapy: A qualitative study.

A Phase 3, 24 week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Efficacy and Safety Study with Open-label Extension of BLU-5937 in Adult Participants with Refractory Chronic COugh Including Unexplained Chronic COugh (CALM-2) Jul 1, 2023 - Apr 30, 2026

Transcend: Setmelanotide versus placebo for treating acquired hypothalamic obesity (Phase 3 study) Aug 1, 2023 - Jul 31, 2025
A Phase 3, Double Blind, Randomised, Placebo[1]Controlled Trial to Evaluate the Efficacy and Safety of Setmelanotide in Patients with Acquired Hypothalamic Obesity

Phase 3 Study to Assess the Efficacy and Safety of Batoclimab for the Treatment of Thyroid Eye Disease (TED): IMVT-1401-3201 TED GO-1 Nov 1, 2023 - Apr 30, 2027
Phase 3 Study to Assess the Efficacy and Safety of Batoclimab for the Treatment of Thyroid Eye Disease (TED)

Fully humanised model of ageing endothelium to study ageing-associated lung diseases: Apr 1, 2024 - Jan 1, 2025

EARLY DIAPAC: EARLY DIAgnosis of PAncreatic Cancer by combined proteomics and genomics testing of pancreatic cyst fluid. Nov 1, 2023 - Dec 31, 2024
This is part of a total project cost of £98,508.70.

Vital Knowledge Exchange Visits: Bolstering Ongoing Collaborative Responsible AI Projects at IIT-M and UoH Feb 1, 2024 - Jul 31, 2024

Extension Study to Assess Batoclimab in Participants with TED Feb 1, 2024 - Jan 31, 2025

Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF) Feb 1, 2024 - Jun 30, 2025